SRRK vs ACVA

Analysts rate Scholar Rock Holding Corporation (SRRK) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison.

The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Scholar Rock Holding Corporation (SRRK) delivered a total return of +51.

4%, compared to -80. 4% for ACV Auctions Inc. (ACVA). Over 10 years, the gap is even starker: SRRK returned +199. 7% versus ACVA's -79. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Scholar Rock Holding Corporation (SRRK) is the lower-risk stock at 1.

31β versus ACV Auctions Inc. 's 1. 33β — meaning ACVA is approximately 2% more volatile than SRRK relative to the S&P 500. On balance sheet safety, ACV Auctions Inc. (ACVA) carries a lower debt/equity ratio of 44% versus 44% for Scholar Rock Holding Corporation — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: ACV Auctions Inc.

grew EPS 18. 8% year-over-year, compared to -33. 2% for Scholar Rock Holding Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Scholar Rock Holding Corporation (SRRK) is the more profitable company, earning 0.

0% net margin versus -8. 7% for ACV Auctions Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SRRK leads at 0. 0% versus -8. 1% for ACVA. At the gross margin level — before operating expenses — ACVA leads at 62. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for ACVA: 38.

5% to $9. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Scholar Rock Holding Corporation (SRRK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+199.

7% 10Y return). Both have compounded well over 10 years (SRRK: +199. 7%, ACVA: -79. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SRRK (Healthcare) and ACVA (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SRRK is a small-cap quality compounder stock; ACVA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.